🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the pharmacokinetics (PK) ...
Status
Completed
Location
Shanghai Xuhui District Central Hospital
Start Date
2022-07-01
Trial ID
NCT05278676
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics, pharmacodynami...
Status
Completed
Location
Japan
Start Date
2015-01
Trial ID
NCT02347046
Treatments Being Tested
A Placebo-controlled, Four Way Crossover Study to Investigate the Effect on...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02515864
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics, pharmacodynami...
Status
Completed
Location
Mochida Investigational sites
Start Date
2017-10-06
Trial ID
NCT03306667
Treatments Being Tested
The primary purpose of the study is to confirm the efficacy of dotinurad 4 ...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2021-12-21
Trial ID
NCT05007392
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics, safety and pha...
Status
Completed
Location
Japan
Start Date
2014-05
Trial ID
NCT02344875
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of dotinura...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-08-01
Trial ID
NCT07089875
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Completed
Location
Japan
Start Date
2013-09
Trial ID
NCT02348333
Treatments Being Tested
To investigate the pharmacodynamics and safety of FYU-981 administered oral...
Status
Completed
Location
Mochida Investigational sites
Start Date
2018-01-04
Trial ID
NCT03375632
Treatments Being Tested
FYU-981 or Febuxostat are administrated to hyperuricemia patients (underexc...
Status
Completed
Location
Mochida Investigational sites
Start Date
2018-01-09
Trial ID
NCT03372200
Treatments Being Tested